INVESTABOT
Equity Research
XNYS · LABORATORY ANALYTICAL INSTRUMENTS · LABORATORY ANALYTICAL INSTRUMENTS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Avantor posted Q1 2026 net sales of $1.58 billion with net income of $43.3 million, down from $64.5 million in the same quarter last year. The headline number masks a currency story: flat reported revenue actually…
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 44,007,348 | $932,955,786 | — | 8/13/2024 |
| Vanguard Group | 64,904,889 | $743,810,028 | — | 1/29/2026 |
| BlackRock | 70,281,231 | $695,784,194 | 7.0% | 8/7/2026 |
| BlackRock | 59,596,926 | $682,980,769 | — | 2/12/2026 |
| BlackRock | 65,703,554 | $515,115,868 | 10.3% | 5/13/2026 |
| State Street | 20,209,406 | $231,599,793 | — | 2/13/2026 |
| State Street | 21,572,974 | $213,572,443 | 4.1% | 8/7/2026 |
| Morgan Stanley | 17,468,418 | $200,188,089 | — | 5/27/2026 |
| State Street | 20,721,079 | $162,453,259 | 2.5% | 5/15/2026 |
| AQR Capital | 11,627,566 | $115,112,902 | 138.9% | 8/14/2026 |
| DE Shaw | 13,110,674 | $102,787,684 | 110.9% | 5/15/2026 |
| DE Shaw | 9,571,523 | $94,758,077 | -27.0% | 8/14/2026 |
| Fidelity (FMR) | 7,670,732 | $87,906,592 | — | 2/17/2026 |
| Fidelity (FMR) | 7,845,462 | $77,670,074 | 3.1% | 8/13/2026 |
| DE Shaw | 6,215,923 | $71,234,478 | — | 2/17/2026 |
| Morgan Stanley | 6,758,161 | $66,905,804 | 10.8% | 8/13/2026 |
| Goldman Sachs | 6,204,341 | $61,422,976 | 65.3% | 8/14/2026 |
| Fidelity (FMR) | 7,610,318 | $59,664,887 | -0.8% | 5/15/2026 |
| AQR Capital | 4,391,597 | $50,327,700 | — | 2/17/2026 |
| Morgan Stanley | 6,098,287 | $47,810,584 | -65.1% | 5/15/2026 |